Logo-npj
Submitted: 25 Jul 2020
Accepted: 07 Aug 2020
ePublished: 12 Aug 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2021;10(2): e11.
doi: 10.34172/npj.2021.11
  Abstract View: 29
  PDF Download: 8

Epidemiology and Prevention

New hope for treatment of respiratory involvement following COVID-19 by bromhexine

Abdolrazagh Barzegar 1 ORCID logo, Masoud Ghadipasha 1 ORCID logo, Nima Rezaei 2,3,4 ORCID logo, Mehdi Forouzesh 1 * ORCID logo, Rohollah Valizadeh 5 ORCID logo

1 Legal Medicine Research Center, Legal Medicine Organization, Tehran, Iran
2 Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
3 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
4 Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5 Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
*Corresponding author: Mehdi Forouzesh, Email: m.frouzesh.forensic@gmail.com

Abstract


Keywords: COVID-19, Bromhexine, Acute kidney injury, Transmembrane serine protease 2 (TMPRSS2), Pneumonia, Angiotensin-converting enzyme 2, Chronic obstructive pulmonary disease

Implication for health policy/practice/research/medical education:

Bromhexine as a fluidifying agent can be investigated in clinical trials to discover its therapeutic effect on respiratory involvement following COVID-19.

Please cite this paper as: Barzegar A, Ghadipasha M, Rezaei N, Forouzesh M, Valizadeh R. New hope for treatment of respiratory involvement following COVID-19 by bromhexine. J Nephropharmacol. 2021;10(2):e11. DOI: 10.34172/npj.2021.11.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 29

Your browser does not support the canvas element.


PDF Download: 8

Your browser does not support the canvas element.